Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens
Open Access
- 1 February 2020
- journal article
- retracted article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 12, 1017-1027
Abstract
Background: Aberrant gene methylation in breast cancer is associated with an unfavorable prognosis. Besides, abnormal Cosmc can induce the expression of Tn and STn antigens. The present study aimed to investigate the roles of Cosmc promoter methylation in breast cancer through the regulation of Tn and STn antigens. Methods: The expression patterns of Cosmc and the Tn and STn antigens in breast cancer cell lines were determined. Cosmc was overexpressed to explore the effects of Cosmc on cell behavior, including the growth, migration, invasion, and apoptosis of breast cancer cells and tumor growth with in vitro and in vivo experiments. Afterwards, a methyltransferase and a methyltransferase inhibitor were used to alter the methylation status of Cosmc to explore the mechanisms related to Cosmc promoter methylation. Results: Cosmc was poorly expressed in breast cancer cells. Cosmc overexpression inhibited cell growth, migration, and invasion while promoting apoptosis in breast cancer cells in vitro and restraining tumor growth in vivo. Cosmc promoter methylation was found to decrease the levels of Cosmc and increased the expression of the Tn and STn antigens in breast cancer. Conclusion: In conclusion, the demethylation of Cosmc mitigates breast cancer progression through the repression of the Tn and STn antigens, which provides evidence for therapeutic considerations for a novel target against breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancerInternational Journal of Oncology, 2013
- Regulation of PCNA–protein interactions for genome stabilityNature Reviews Molecular Cell Biology, 2013
- The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERKMolecular Carcinogenesis, 2013
- Effects of EdU labeling on mesenchymal stem cellsCytotherapy, 2013
- Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn AntigenJournal of Biological Chemistry, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Tight Complex Formation between Cosmc Chaperone and Its Specific Client Non-native T-synthase Leads to Enzyme Activity and Client-driven DissociationJournal of Biological Chemistry, 2012
- Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancerEuropean Journal of Surgical Oncology, 2011
- A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple MalignanciesPLOS Medicine, 2006
- A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferaseProceedings of the National Academy of Sciences, 2002